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dysfunction. Here we describe methods for analysis of mitochondrial 
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Significance Statement 
Mitochondria are organelles that play a key role in energy production in our cells. They use 
oxidative phosphorylation for producing ATP. Mitochondria have their own genome and 
protein synthesis for producing the core protein components of the oxidative phosphorylation 
system. The protocols described here are for investigating the production and stability of these 
core proteins and the oxidative phosphorylation complexes in mitochondria of cultured cells.   
 
ABSTRACT 
Mitochondria are multifunctional organelles with their own genome and protein synthesis 
machinery. The 13 proteins encoded by mitochondrial DNA (mtDNA) are core subunits of the 
oxidative phosphorylation (OXPHOS) system producing the majority of cellular ATP. Yet most 
mitochondrial proteins are encoded by nuclear genes, synthesized by cytosolic ribosomes and 
imported into mitochondria. Therefore, disturbances in cytosolic proteostasis have 
consequences on the gene expression and synthesis of mtDNA-encoded proteins and overall on 
mitochondrial function. Internal and environmental factors such as mutations, aging, oxidative 
stress and toxic agents can affect the translation and the stability of mitochondrial proteins and 
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lead to OXPHOS dysfunction. Here we describe methods for analysis of mitochondrial 
translation rate and protein stability using radioactive and non-radioactive technique as well as 
the methods for studying steady state levels and assembly of OXPHOS complexes. 
 
Keywords: proteostasis, mitochondria, protein synthesis, OXPHOS complexes 
 
INTRODUCTION 
Mitochondria are multifunctional organelles requiring the input of two genomes and two 
protein synthesis machineries (Hallberg and Larsson, 2014; Nunnari and Suomalainen, 2012; 
Hilander et al., 2018). Mammalian mitochondrial ribosomes produce 13 core protein subunits 
of the oxidative phosphorylation (OXPHOS) complexes, which are responsible for the 
production process of most cellular ATP. These 13 proteins are encoded by mitochondrial DNA 
(mtDNA), as well as the 22 tRNAs and 2 rRNAs involved in their synthesis. The rest of the 
mitochondrial proteome, about 1500 proteins, is encoded by the nuclear genome, synthesized 
by cytosolic ribosomes, and imported into mitochondria. The imported proteins include all 
protein components of the mitochondrial gene expression and protein synthesis machinery, 
such as the aminoacyl-tRNA synthetases and mitoribosomal proteins, as well as the rest of 
OXPHOS complex subunits. Thus, mutations either in mitochondrial or in nuclear genes can 
cause defects in mitochondrial translation and in the function of OXPHOS complexes.  
As the imported mitochondrial proteins must be first synthesized in the cytosol, disturbances 
in cytosolic proteostasis may also have severe consequences for mitochondrial OXPHOS 
function, and also for other functions of the mitochondria for example in anabolic processes 
and regulation (D'Amico et al., 2017). For example, the incorporation of arginine analog 
canavanine into newly synthesized proteins causes major protein misfolding in cytosol and 
protein instability in mitochondria, which both contribute to a severe OXPHOS defect 
(Konovalova et al., 2015). In relation to the bacterial origin of mitochondria, some antibiotics 
such as tetracycline also disturb the mitochondrial protein synthesis (Moullan et al., 2015). 
As methods to study mitochondrial protein translation and the stability of OXPHOS 
complexes we recommend to use in vivo mitochondrial translation assays and blue –native 
PAGE (BN-PAGE) of assembled OXPHOS complexes. For the in vivo mitochondrial translation 
assay, cells are grown with radioactively labeled amino acids, while simultaneously blocking the 
cytosolic protein translation with antibiotics such as anisomycin or emetine. This enables the 
labeling of the proteins synthesized by mitoribosomes only. With a short pulse of radioactively 
labeled amino acids, the translation rate of the 13 mtDNA encoded proteins can be evaluated. 
By washing the extra label away from the cells, followed by a chase period, the stability of the 
proteins can be estimated. This method is a powerful tool to study the function of the entire 
translation process in mitochondria. We have also utilized a puromycin-based non-radioactive 
method for testing mitochondrial translation rate (Konovalova et al., 2015), which was 
previously successfully applied for analysis of protein translation rate in cytoplasm (Schmidt et 
al., 2009; Miyamoto-Sato et al., 2000). 
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By BN-PAGE, the assembly and stability of the entire OXPHOS complexes can be evaluated. 
First, mitochondria are extracted from cells or tissues, after which the OXPHOS complexes are 
extracted in native state from the mitochondria and run on a native gel.  
When testing the effect of a transient stress on the stability of the OXPHOS complexes and 
their subunits, it may be necessary to block the mitochondrial translation for example with an 
antibiotic chloramphenicol before the stress treatment, because the lifetime of OXPHOS 
subunits and the entire complexes can be more than 48 hours in cultured cells, and therefore 
the effects of the stress cannot be easily detected. In such cases we have depleted the OXPHOS 
complexes by chloramphenicol for 48 hours and followed the recovery of the complexes or 
their subunits under the stress treatment (Konovalova et al., 2015). 
 
BASIC PROTOCOL 1 
IN VIVO MITOCHONDRIAL TRANSLATION ASSAY  
The purpose of this assay is to study the translation rate and stability of the 13 mtDNA encoded 
proteins by using radioactively labeled amino acids simultaneously with a blocker of 
cytoplasmic protein translation. The following protocol is modified from (Fernandez-Silva et al., 
2007). 
Materials 
Cultured adherent cells  
Cell culture medium (for example: DMEM (Lonza Cat# 12-614F/12), 10% FBS (Life Technologies 
Cat# 10270106), 1% Penicillin Streptomycin (Lonza Cat# 17-602E), 1% L-glutamine (Life 
Technologies Cat# 25030024)) 
Labeling medium (cell culture medium without methionine and cysteine). For labeling media 
use DMEM without methionine and cysteine (Life Technologies Cat# 21013024) and dialyzed 
FBS (Life Technologies Cat# 26400036).  
PBS (Life Technologies Cat# BE17-516F) 
Inhibitor of cytoplasmic protein translation, emetine or anisomycin (see recipe) 
35
S-methionine or mixture of
 35
S-methionine and 
35
S-cysteine (for example EXPRE35S Protein 
Labeling Mix from Perkin- Elmer Cat# NEG072007MC). Pure 
35
S-methionine gives the 
strongest signal and the best signal/noise ratio, but the mixture of methionine and cysteine 
is less expensive and the signal intensity is about 75% compared to the methionine only) 
Protease inhibitors (Thermo Scientific Cat# 10137963) 
Protein assay kit (Bradford, BioRad Cat# 5000006)   
40% Acrylamide/Bis 37.5:1 (Bio-Rad Cat# 161-0148)  
1.5 M Tris-HCl pH 8.8 (Tris base (Fisher BioReagents Cat# BP152)) 
1 M Tris-HCl pH 6.8 (Tris base (Fisher BioReagents Cat# BP152)) 
ddH2O 
100% Glycerol (Sigma Cat# G5516) 
20% SDS (Fisher Cat# 10607443) 
10% Ammonium persulfate (Sigma Cat# A3678) 
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N,N,N′,N′-Tetramethylethylenediamine (TEMED) (Sigma Cat# T9281) 
Loading dye (see recipe) 
Tris-Glycine-SDS running buffer (see recipe) 
Coomassie staining solution (Bio-Rad Cat# 161-0786) 
 
60 mm cell culture dishes (Thermo Fisher Scientific Cat# 150288) 
Cell scrapers (Fisher Cat# 11597692) 
Gradient maker (Gradient Former Bio-Rad Cat# 1654120) 
16 x 18 cm sized gel electrophoresis system (Amersham Cat# 80-6155-24) 
Gel drying equipment (Fisher Scientific GD 2000 Gel Dryer System) 
 
Additional reagents and equipment for centrifugations, protein concentration measurement 
and running of the gel. 
 
Notes before starting: 
• The cells should be grown in 60 mm plates. Cell confluency should be 75-90%. One 
plate/sample provides enough proteins for one experiment. Enough plates should be 
made to ensure replicates.  
• Prepare the gel the day before the experiment (see recipe for 12-20% acrylamide 
gradient gel). 
• Preincubate the required volumes of labeling medium (2 ml/plate) and the normal cell 
culture medium (5 ml/plate) for at least 30 minutes in cell culture incubator (equilibrate 
to 5% CO
2
 and 37 °C). 
• During the labeling procedure, individual cell plates should be placed separately on the 
shelf of the incubator, not stacked on top of each other. 
• For pulse experiments either anisomycin (reversible inhibitor of cytoplasmic translation) 
or emetine (irreversible inhibitor of cytoplasmic translation) can be used. For chase 
labeling only anisomycin is used. 
•     
35
S is harmful. Wear lab coat and gloves for protection. Avoid inhalation. Collect all 
the radioactive liquid and plastic produced during sample preparation. Put the 
radioactive waste in labeled sealed containers and hold for decay according to the 
institutional regulations.  
Protocol steps: 
1. Remove the culture media and immediately wash the cells twice with PBS.  
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2. Incubate the cells for 30 minutes in labeling medium (2 ml/60 mm plate). During this 
time, 2 mg/ml of inhibitor of cytoplasmic protein translation can be prepared 
(anisomycin for pulse and chase labeling, emetine or anisomycin for pulse labeling). 
3. Add the inhibitor of cytoplasmic protein translation to each plate (100 µl/2 ml of 
labeling medium, final concentration 100 µg/ml) and incubate for minimum of 5 min. 
4. Add 400 µCi of 
35
S-methionine or mixture of 
35
S-methionine and 
35
S-cysteine to each 
plate (final concentration 200 μCi/ml) and incubate for 15-60 minutes. 
The labeling time can be adjusted based on the purpose of the analysis (see section 
Critical Parameters).  
5. For pulse labeling, chase cells in the normal preincubated cell culture medium (5 
ml/plate) for 10 minutes. For chase labeling, wash cells once with the normal 
preincubated cell culture medium and then chase the cells in the same medium (5 
ml/plate) for 1-48 hours.  
Chasing allows finishing the protein translation products in the pulse experiments, but 
is not always necessary, and enables the follow up of the stability of radioactively 
labeled proteins in the chase experiments. The chase time can also be adjusted based 
on the purpose of the analysis (see section Critical Parameters). 
 
6. After the incubations, remove medium and wash the cells twice with PBS.  
7. Scrape the cells in 4 ml ice-cold PBS and transfer to 15 ml falcon tube. Centrifuge the 
cells at 1000 g for 7 minutes at +4 °C. 
Alternatively, trypsinize the cells. Samples can now be stored at -80 °C. 
8. Resuspend pellet in 50-200 µl ice-cold PBS with protease inhibitors. Adjust the volume 
of PBS according to the size of the cell pellet to get equal protein concentrations in the 
next step and keep on ice. 
9. Determine the protein concentration by Bradford assay. 
10. Take 30-60 µg of protein from each sample and spin the proteins down at full speed 
(13000 g – 20000 g) for 20 minutes at 4 °C. 
11. Resuspend the pellet in 33 µl of 1 x loading dye.  
Samples should be kept at room temperature to avoid precipitation of SDS. 
12. Sonicate the samples 2 times for 3 seconds with 50% intensity. 
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13. Spin samples at full speed at room temperature, for 10-15 minutes, or until foam 
disappears.  
To make sure that the samples are not getting warm, set the temperature of the 
centrifuge to +22 °C. Samples can be also stored at -80 °C. 
14. Wash the wells of the 12-20% gradient polyacrylamide gel with ddH2O, remove the 
water and fill the wells with running buffer.  
15. Load the samples and run the gel with 10 mA and 100 V until the samples are inside the 
gel. Transfer the gel to cold room, if not already there, and run with 10 mA, 150 V until 
the blue loading dye line runs out of the gel (about 16 h).  
16. Place the gel on the Whatman filter paper, cover with plastic film and dry the gel (65 °C, 
under vacuum, for 1 h). 
17. Expose the dried gel to the phosphor screen by keeping the gel in phosphoImager 
cassette (3 days is usually enough). 
18. Image the screen. 
19. Rehydrate the gel in ddH2O on a gently rocking surface for one hour. 
20. Stain the gel with coomassie on a gently rocking surface for one hour.  
21. Wash the gel several times with ddH2O on a gently rocking surface and leave the gel in 
ddH2O overnight on the shaker. 
22. Image the gel. 
 
ALTERNATE PROTOCOL 1 (optional) 
IN ORGANELLO TRANSLATION ASSAY 
The translation rate and stability of the 13 mtDNA encoded proteins can also be studied in 
isolated mitochondria. This might be useful when the effects of non-mitochondrial factors 
should be excluded from the analysis. Only high quality functional mitochondria can be used for 
this experiment. The translation assay on isolated mitochondria is performed similarly as 
described above with some modifications. 
Materials 
Cultured adherent cells 
PBS (Life Technologies Cat# BE17-516F) 
Mitochondrial isolation buffer (MIB, see recipe) 
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Translation buffer (see recipe) 
 
150 mm cell plates (Thermo Fisher Scientific Cat# 168381) 
Dounce (glass-glass) homogenizer (volume for 10 ml) 
Rotary wheel 
 
The rest of the materials and equipment are the same as for the in vivo mitochondrial 
translation assay. 
 
Notes before starting:  
• The cells should be grown on 150 mm plates. Cell confluency should be 75-90%. One 
150 mm plate/sample provides enough mitochondria for the experiment. 
• Remember to be fast and efficient, but gentle at the same time. Mitochondria must be 
fully functional and able to respire during labeling! 
• This protocol can also be used for mitochondria extracted from tissues. Check 
instructions for mitochondria isolation from different tissues from (Fernandez-Vizarra et 
al., 2010). 
 
Protocol steps: 
1. Remove the culture media and immediately wash the cells once with PBS. 
2. Scrape the cells from the plates and pellet them at 1000 g for 7 min at +4 °C.  
3. Wash the cell pellets with cold PBS and pellet the cells again. 
4. Resuspend the cells in 10 ml of MIB with BSA and homogenize the cells by 50 strokes 
with tight Dounce (glass-glass) homogenizer. Keep the homogenizer on ice during the 
whole homogenization step. 
Different cell types might need optimization of the homogenization.  
5. Centrifuge the samples at 1000 g for 5 min at +4 °C. 
Unbroken cells end up in the pellet in this step. 
6. Take the supernatant and centrifuge at 9000 g for 10 min to pellet down mitochondria. 
7. Wash the mitochondria pellet with 5 ml of MIB with BSA at 9000 g for 10 min at +4 °C. 
8. Repeat step 7. 
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9. Resuspend mitochondrial in 5 ml isolation buffer without BSA. 
10. Measure protein concentration using Bradford assay. 
11. Pellet 2 mg of the mitochondrial protein at 9500 g for 2 min at +4 °C. 
 
      Take 1 mg of the mitochondrial protein if you need only pulse labeling. 
12. Remove supernatant and resuspend in 2 ml translation buffer. 
 
13. Centrifuge at 9500 g for 2 min at +4 °C. 
 
14. Resuspend pellet in 2 ml translation buffer and add 30 µl of 
35
S-methionine.  
 
15. Incubate 1 h at 37 °C in a rotary wheel. 
 
16. Centrifuge at 9500 g for 2 min. 
 
17. Resuspend pellet in 1 ml translation buffer. 
 
18. Split mitochondrial suspension into two tubes by pipetting 0.5 ml to each tube. One of 
the tubes will be for pulse labeling and the other one is for chase labeling. 
 
19. Centrifuge at 9500 g for 2 min. 
 
20. Tube 1 (pulse): resuspend pellet in 30 µl loading dye and leave at room temperature for 
30 min. 
 
21. Tube 2 (chase): resuspend pellet in 650 µl translation buffer with added cold methionine 
(final concentration 60 µg/ml) and incubate three hours at 37 °C in a rotary wheel. 
 
22. Proceed with the steps 16 – 20 for tube 2. 
 
Samples can now be stored at -80 °C. 
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23. The labeled mitochondrial proteins (150 to 300 mg total protein/lane) are separated by 
SDS-PAGE as described in the previous protocol (steps 14 – 21).  
 
 
ALTERNATE PROTOCOL 2  
NONRADIOACTIVE MITOCHONDRIAL TRANSLATION ASSAY 
The translation rate of the 13 mtDNA encoded proteins can also be studied with a 
nonradioactive method using the amino acid analog puromycin. Puromycin is a structural 
analog of tyrosyl-tRNA and it can enter the A-site of the ribosome incorporating into the newly 
synthetized proteins. Puromycin, however, causes premature chain release and thus its 
incorporation can be used only for evaluation of the translation rate. In the nonradioactive 
mitochondrial translation assay puromycin is used instead of radioactively labeled amino acids 
in the presence of emetine (a blocker of cytoplasmic translation) after which proteins are 
extracted from the cells and used for normal SDS-PAGE and western blotting followed by 
antibody based signal detection of puromycin.  
Materials 
Cultured adherent cells  
PBS (Life Technologies Cat# BE17-516F) 
Puromycin (Sigma Cat# P8833) 
Emetine (Sigma Cat# E2375) 
RIPA (see recipe) 
Proteinase inhibitors (Thermo Scientific Cat# 10137963) 
Anti-Puromycin antibody (Millipore Cat# MABE343, RRID:AB_2566826) 
 
6-well plates (minimum) (Thermo Fisher Scientific Cat# 140675) 
 
Additional reagents and equipment for protein concentration measurement, sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) running, and immunoblotting. 
 
Notes before starting: 
• The cells are grown in 6-well plates. Cell confluency should be 75-90%. Each well from 6-
well plate provides enough proteins for the experiment. 
 
Protocol steps 
1. Change fresh media to the cells. 
2. Preincubate cells with 100 μg/ml of emetine for 10 min. 
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3. Add 10 μg/ml of puromycin and incubate 20 min. 
Different cell lines might need optimization of the incubation time with puromycin.  
It is good to include two samples as negative controls. One, which in addition to emetine 
has 100 μg/ml of chloramphenicol at step 2. Another one without puromycin at step 3. 
4. Wash the cells once with PBS. 
5. Scrape the cells into ice cold PBS and pellet the cells at 1000 g 10 min at +4 °C. 
Samples can now be stored at -80 °C. 
 
6. Resuspend the cell pellets in 1 x RIPA with proteinase inhibitors and incubate on ice for 
10 min. 
7. Centrifuge the samples at 14000 g for 10 min at +4 °C. 
8. Take supernatant to a new tube and measure protein concentration using Bradford 
assay. 
Samples can now be stored at -80 °C. 
 
9. Run samples on SDS-PAGE. Use 30 μg of protein for each sample.  
10. Transfer the gel to PVDF or nitrocellulose membrane by manufacturer’s instructions. 
11. Block the membrane with 5% milk in TBST for 1 h. 
12. Wash the membrane on a shaker 5 min three times in 1 x TBST to remove traces of milk 
before adding the antibody. 
13. Incubate the membrane with anti-puromycin antibody (1:25000 in the case of the 
suggested antibody) in 1% BSA/TBST on a shaker over night at +4 °C.  
14. Wash the membrane three times for 15 min each with 1 x TBST on a shaker. 
15. Incubate the membrane with the secondary antibody in 1% BSA/TBST (according to 
manufacturer’s instructions) for at least 1 h at room temperature on a shaker. 
16. Wash the membrane three times for 10 min each with 1xTBST on a shaker. 
17. Image protein bands using a chemiluminescence detection kit according to the 
manufacturer’s instructions and repeat the steps 13 - 17 with a loading control 
antibody. 
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 BASIC PROTOCOL 2  
BLUE NATIVE POLYACRYLAMIDE GEL ELECTROPHORESIS (BN-PAGE) 
BN-PAGE enables to separate intact protein complexes and can be used to study assembly of 
mitochondrial protein complexes. In this method mitochondria are extracted from cells using 
digitonin, which brakes the outer membrane of the cells. Isolated mitochondria are treated 
with lauryl maltoside, which releases the OXPHOS complexes from the mitochondrial 
membranes.  
Materials 
Chloramphenicol (see recipe) 
PBS (Life Technologies Cat# BE17-516F) 
Protease inhibitors (Thermo Scientific Cat# 10137963) 
Digitonin (see recipe) 
Lauryl maltoside (n-Dodecyl β-D-maltoside) (Sigma Cat# D4641) 
MB2 buffer (see recipe) 
Blue Native loading dye (see recipe) 
3 x Gel buffer (see recipe) 
40% Acrylamide/Bis 37.5:1 (Bio-Rad Cat# 161-0148) 
ddH2O 
100 % Glycerol (Sigma Cat# G5516)  
Ammonium persulfate (prepare fresh) 
N,N,N′,N′-Tetramethylethylenediamine (TEMED) (Sigma Cat# T9281) 
 
Cathode buffer (see recipe) 
Blue cathode buffer (see recipe) 
Anode buffer (see recipe) 
Antibodies against respiratory chain complexes. For example, Complex I (NDUFA9, Abcam Cat# 
ab14713, RRID:AB_301431), Complex II (SDHA, Abcam Cat# ab14715, RRID:AB_301433), 
Complex III (UQCRC2, Abcam Cat# ab14745, RRID:AB_2213640) and Complex IV (MTCOI, Abcam 
Cat# ab14705, RRID:AB_2084810). 
 
100 mm cell plates (Thermo Fisher Scientific Cat# 130182) 
 
Additional equipment for protein concentration measurement, gel running, and 
immunoblotting. 
 
Notes before starting  
• The cells are grown on 100 mm plates. Cell confluency should be 80-90%. One 100 mm 
plate/sample provides enough proteins for the experiment. 
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• Perform all the steps at +4 °C and do not vortex. 
 
Protocol steps 
Sample preparation 
1. Wash the cells once with ice cold PBS. 
2. Scrape the cells and pellet them at 1000 g for 10 min at +4 °C. 
3. Resuspend the cells in 1 ml ice cold PBS with protease inhibitor. 
4. Pellet the cells at 1000 g for 10 min (use 2ml Eppendorf tubes). 
5. Resuspend the cells in 1 ml PBS with protease inhibitors. 
6. Measure protein concentration with Bradford method. 
7. Pellet the cells at 1000 g for 10 min at +4 °C. 
8. Resuspend the cells in PBS with protease inhibitor to a final concentration of 5 mg/ml. 
9. Add 4 mg/ml digitonin to final concentration of 2 mg/ml. Mix well and incubate on ice 
for 5 min. 
The concentration of digitonin/cell type might need optimization. Digitonin is a mild 
detergent and brakes the cell membrane freeing mitochondria into the solution.  
10. Add PBS with proteinase inhibitor to final volume of 1.5 ml. 
11. Centrifuge at 10 000 g for 10 min at +4 °C. 
In this step mitochondria are pelleted. 
12. Resuspend the pellets in MB2 buffer. The volume of MB2 is half of the volume of PBS in 
step 8. 
13. Add 10% lauryl maltoside to final concentration of 1%. Incubate on ice for 15 min (this 
step can be longer up to a couple of hours). 
Lauryl maltoside brakes mitochondrial membranes and releases OXPHOS complexes 
in the solution. 
14. Centrifuge at 20000 g for 20 min at +4 °C. 
15. Put the supernatant into a new Eppendorf tube and measure protein concentration. 
16. Add loading dye, a volume that is half of the volume of lauryl maltoside used in step 13.  
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Samples can now be stored at -80 °C. 
Gel electrophoresis 
1. Prepare 6-15 % separating gel with gradient gel mixer according to the table in the 
reagents and solutions section. 
2. After polymerization of the separating gel wash it with 1 x GB. 
3. Prepare stacking gel mixture according to table in the reagents and solutions section, 
insert comb and fill up to the top with stacking gel mixture. 
4. After polymerization of the stacking gel remove the comb and wash the wells with 1 x 
GB. 
5. Fill the gel cassette with the blue cathode buffer until the bottom of the wells and fill 
the wells with the blue cathode buffer. Loading of the samples is easier when the 
cassette is not filled to the top. 
6. Load the samples (5-30 µg of protein) into wells.  
7. Fill the gel cassette to the top with the blue cathode buffer and the tank with anode 
buffer. 
8. Run the gel for 15 min at 40 V, then increase to 80 V (or 6 mAmp, do not exceed 10 
mAmp) until the dye reaches to 2/3 of the gel.  
9. Replace the blue cathode with cathode buffer and continue electrophoresis until the 
dye front is run out. The gel run takes about 4 h. 
10. Continue with the protein transfer, blocking and antibody incubation as in the steps 10 – 
17 for the nonradioactive mitochondrial translation assay. Use the primary antibodies 
against OXPHOS complexes sequentially. 
ALTERNATE PROTOCOL 2 (optional) 
SDS-PAGE OF OXPHOS COMPLEX SUBUNIT RECOVERY UNDER A SPECIFIC TREATMENT 
In addition to studying the entire OXPHOS complexes by BN-PAGE, the individual subunits of 
OXPHOS complexes can also be investigated by SDS-PAGE. If either PAGE is done to evaluate 
the effects of a stress treatment, it may be useful to deplete OXPHOS subunits first by 
pretreating the cells with 30-40 µg/ml of chloramphenicol for 48 h, because the OXPHOS 
complexes and subunits can be stable in cultured cells up to 48 h. Following the pretreatment, 
the recovery of the complexes can be followed and compared between treated and non-
treated cells. See for example Fig. 4 in Konovalova et al. for the effects on recovery after 
canavanine treatment. 
Materials 
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Chloramphenicol (see recipe) 
 
 
REAGENTS AND SOLUTIONS 
 
Inhibitors of cytoplasmic translation  
2 mg/ml of either emetine (Sigma Cat# E2375) (for pulse labeling) or anisomycin (Sigma 
Cat# A9789) (reversible, for pulse and chase labeling) in PBS. Filter sterilize. Prepared 
fresh prior to use. 
 
 
2 x loading dye (in vivo and in organello mitochondrial translation assay)  
186 mM Tris-HCl, pH 6.7-6.8 (Tris base (Fisher BioReagents Cat# BP152)) 
15% glycerol (Sigma Cat# G5516) 
2% SDS (Fisher Cat# 10607443) 
0.5 mg/ml bromophenol blue (Sigma Cat# B5525) 
 
The 2 x loading dye can be stored up to one year without β-mercaptoethanol at -20°C. 
Prepare fresh 1 x loading dye just prior the sample run using 2 x loading dye and ddH20. 
Add β-mercaptoethanol to final concentration of 6% to the 1 x loading dye. For example, 
to prepare 500 µl ready to use loading dye take 250 µl 2 x loading dye add 220 µl ddH20 
and 30 µl β-mercaptoethanol.  
 
12-20% Acrylamide gradient gel 
    Resolving gel 12% Resolving gel 20% Stacking gel 
40% Acrylamide-Bis 37:1 3.6 ml   6.2 ml   1.5 ml 
1.5 M Tris-HCl pH 8.8  3 ml   3 ml   - 
1M Tris-HCl pH 6.8  -   -   2.5 ml 
ddH20    4.2 ml   1.6 ml   6 ml 
100% glycerol   1.2 ml   1.2 ml   - 
20% SDS   60 µl   60 µl   50 µl 
10% Ammonium persulfate 60 µl   36 µl   100 µl 
TEMED   7 µl   4.8 µl   10 µl 
 
Keep mixtures on ice and use fresh. Add SDS (forms bubbles), APS and TEMED (they 
start the polymerization) last. Mix gently avoiding air bubbles. Do not vortex. Use 9.2 ml 
of 12% and 9.7 ml of 20% gel to the gradient gel mixer for one 16 x 18 cm sized gel. The 
ready gel can be stored at +4 °C for up to 2-3 days. 
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5 x Tris-Glycine-SDS running buffer  
15 g Tris base (Fisher Bioreagents Cat# BP152) 
72 g Glycine (Thermo Scientific Cat# G/P460/53) 
3 g SDS (Fisher Cat# 10607443) 
 
Fill up to 1 liter with ddH20. 5 x Tris-Glycine-SDS running buffer can be stored at +4 °C up 
to one year. Using ddH20 prepare 1 x Tris-Glycine-SDS running buffer prior to use. 
 
Mitochondrial isolation buffer (MIB, in organello mitochondrial translation assay) 
320 mM sucrose (Sigma Cat# S7903) 
1 mM EDTA (Life Technologies Cat# 15575-038) 
10 mM Tris-HCl (Tris base (Fisher Bioreagents Cat# BP152)) 
 
Adjust pH to 7.4. Can be stored at +4 °C for one week. Prepare MIB without BSA and 
with BSA (BioWest Cat# P6154) (1 mg/ml).  
 
Translation buffer (in organello mitochondrial translation assay) 
 
     Volume Final concentration 
2 x translation mix  5ml    
Amino acids (6 mg/ml each) 100 µl  60 µg/ml 
200 mM ATP   250 µl  5 mM 
50 mM GTP   40 µl  20 µM 
1 M creatine phosphate 60 µl  6 mM 
10 mg/ml creatine kinase 60 µl  60 µg/ml 
Cysteine (6 mg/ml)  100 µl  60 µg/ml 
Tyrosine (3 mg/ml)  200 µl  60 µg/ml 
ddH20    4.595 ml 
 Total volume   10 ml 
 Do not add cysteine to translation buffer in case of using 
35
S-mehionine and 
35
S-cysteine 
mixture. 
Always prepare fresh 200 mM ATP: 60.5 mg ATP in 485 µl ddH20, add 15 µl 10 M KOH to adjust 
pH to 7.0.  
Always prepare fresh 50 mM GTP: 2.8 mg in 100 µl ddH20. 
 
2 x translation mix for translation buffer 
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200 mM mannitol (Sigma Cat# M9647) 
20 mM sodium succinate (Sigma Cat# S2378) 
160 mM KCl (Sigma Cat# P9333) 
10 mM MgCl2 (Amresco Cat# 7791-18-6) 
2 mM KPi (Sigma Cat# P5655) 
50 mM HEPES (Life Technologies Cat# 15630049) 
 
Adjust pH to 7.4. Can be stored at -20 °C for several months. 
 
Chloramphenicol 
1 mg/ml of chloramphenicol (Sigma Cat# C3175) in basic medium (DMEM) without 
serum and other additional components. Add warm medium to the powder and 
incubate at 37 °C until the powder dissolves. Filter sterilize. Can be stored at 4 °C for one 
week. 
1 x RIPA  
20 mM Tris-HCl pH 7.5 (Tris base (Fisher BioReagents Cat# BP152)) 
150 mM NaCl (Fisher BioReagents Cat# BP358) 
1 mM Na2EDTA 
1 mM EGTA (Sigma Cat# E4378)  
1% NP-40 (Fluka BioChemika Cat# 74385) 
1% sodium deoxycholate (Sigma Cat# 30970)  
2.5 mM sodium pyrophosphate  
1 mM β-glycerophosphate (Sigma Cat# G9422) 
1 mM Na3VO4 (Sigma Cat# S6508) 
 
Can be stored at -20 °C up to one year. Alternatively, commercial RIPA lysis buffer can    
be used (Cell Signaling Technology, 9806S).  
 
Digitonin 
Note: Digitonin is toxic! Be cautious and use face mask and other protection! Dissolve 4 
mg/ml digitonin (Sigma Cat# D141) in PBS (Life Technologies Cat# BE17-516F) at 100 °C 
until no precipitate is visible and cool on ice immediately. Add protease inhibitor. Use 
fresh. 
 
3x  Gel buffer (3 x GB)  
1.5 M aminocaproic acid (Sigma Cat# A2504) 
150 mM Bis-tris (Sigma Cat# B7535) 
  
Adjust pH to 7.0. Can be stored at +4 °C up to one year. 
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BN-PAGE gel 
 
     Separating 6%  Separating 15%   Stacking 4% 
    gel   gel   gel 
3 x GB    3.3 ml   3.3 ml   1.64 ml 
40% Acrylamide/Bis 37.5:1 1.5 ml   3.75 ml  0.5 ml 
ddH2O    5.14 ml  0.9 ml   2.8 ml 
100% Glycerol   0    2   0 
10% Ammonium persulfate 60 µl   10 µl   60 µl 
TEMED   4 µl   2 µl   6 µl 
 
Keep mixtures on ice and use fresh. Add APS and TEMED (they start polymerization) last. 
Mix gently avoiding air bubbles. Use 2.6 ml of 6% gel and 2.1 ml 15% gel to the gradient 
gel mixer for one 8.3 x 7.3 cm sized gel. From the recipe above at least three gels can be 
casted. 
 
Cathode buffer 
15 mM Bis-tris (Sigma Cat# B7535) 
50 mM Tricine (Sigma Cat# T9784) 
 
Adjust pH to 7.0. Can be stored at +4 °C up to one year. 
 
Blue cathode buffer  
Add 0.02% Serva Blue G (Serva Cat# 35050) to cathode buffer. 
 
Can be stored at +4 °C up to one year. 
 
Anode buffer  
50 mM Bis-tris (Sigma Cat# B7535) 
 
Adjust pH to 7.0. Can be stored at +4 °C up to one year. 
 
MB2 buffer 
1 M Aminocaproic acid (Sigma Cat# A2504) 
2 mM EDTA (Life Technologies Cat# 15575-038) 
 
Use 3 x GB to adjust the volume. Can be stored at +4 °C up to one year. 
 
Loading dye for BN-PAGE 
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750 mM Aminocaproic acid (Sigma Cat# A2504) 
5% Serva Blue G (Serva Cat# 35050)  
 
Can be stored at room temperature up to one year. 
 
COMMENTARY 
Background Information 
The simplest method to study the steady state level of mtDNA-encoded proteins is the basic 
SDS-PAGE followed by western blotting. However, western blotting allows to study only 
individual OXPHOS subunits, which requires specific antibodies and is time-consuming. In 
addition, the stability and the translation rate of entire complexes and of individual proteins 
cannot be studied using western blotting. The mitochondrial translation assays enable the 
evaluation of the stability and the translation rate of all the 13 mtDNA encoded proteins at the 
same time. The BN-PAGE allows to evaluate the assembly of OXPHOS subunits and when BN-
PAGE is applied after depletion of mtDNA-encoded proteins the assemble rate of the entire 
complexes can be studied. Thus, here we described the methods allowing the study of 
mitochondrial translational processes and assembly of OXPHOS subunits. 
 
Critical Parameters and Troubleshooting 
In our laboratory human osteosarcoma cells (143B), embryonic kidney cells (HEK293), 
neuroblastoma cells (SH-SY5Y), and primary myoblasts and myotubes have been successfully 
used for all of the protocols. Each protocol is adjustable to also other cell types. The in 
organello mitochondrial translation assay and BN-PAGE are adjustable also to different tissue 
samples. Different cell and tissue types might need, however, some optimization of the 
different steps in the protocols, such as the sufficient amount of cells, the length of 
chloramphenicol treatment or the method of homogenization.  
In the mitochondrial translation assays, the pulse and chase times can vary depending on the 
purpose of the study. When studying protein translation rate, short pulse labeling time (15-45 
min) without chase is recommended. When the stability of the proteins is to be studied, several 
different chase time points are usually required (2h and more). The pattern of the labeled 
proteins in the gel is usually constant between different cell types, but small changes in the 
abundance and migration of individual proteins might be seen.  
For the in organello mitochondrial translation assay, the mitochondrial extraction is the most 
critical step of the protocol. Because mitochondria need to be metabolically active for the 
labeling step, the extraction must be done fast and efficiently, but at the same time gently 
enough. Thus, the homogenization step should be optimized for different cell types. One 
important step of the extraction is the washing of the mitochondrial pellet to discard 
contaminations from the cytoplasm. It is also important to keep the mitochondria well 
oxygenated throughout the labeling procedure, which can be assured by using the rotary 
wheel. 
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The frequent problem with the radioactive translation methods is a low signal. In this case, 
the fresh radioactive label of sufficient amount should be used. In case of high background, the 
correct handling of the samples (especially the temperature) should be checked. 
For the BN-PAGE the most critical part of the protocol is the handling of the cells and the 
extraction of the mitochondrial proteins. Different cell types might need some adjustment of 
cell to detergent ratios. 
 
Understanding Results 
The radioactive translation assay enables visual detection of all the 13 mtDNA encoded proteins 
within one assay (Figure 1A). Pulse labeling allows to evaluate the rate of mitochondrial 
translation, whereas the chase labeling enables to investigate whether the stability of the newly 
synthesized proteins is affected. The normalization of the results to the amount of total loaded 
protein can be done by coomassie staining of the gel. The band intensity of mitochondrial 
proteins can be quantified separately or all together.  
With the nonradioactive translation assay only the translation rate in general, not the rate or 
stability of individual proteins, can be detected. For quantification analysis the immunoblot 
signal of puromycin should be normalized to a loading control (any housekeeping protein such 
as GAPDH or β-tubulin).  
The BN-PAGE allows the evaluation of intact OXPHOS complexes (Figure 1B).  The molecular 
weights of the complexes are about 1000 kDa (complex I, CI), 600 kDa (complex V, CV), 500 kDa 
(complex III, CIII), 200 kDa (complex IV, CIV) and 130 kDa (complex II, CII). In addition, the 
complexes exist in higher-order supercomplexes, of which some might be detected with the 
described method. Typically, no good loading controls are available for BN-PAGE, which puts 
emphasis on equal loading of protein and repeated experiments. Also, of the five OXPHOS 
complexes, only complexes I, III, IV and V contain subunits encoded by mtDNA, whereas 
complex II is entirely encoded by nuclear genes. Therefore, if mitochondrial protein synthesis is 
blocked, decreases may be seen in the amounts of CI, or CIII-CV, but the amount of CII should 
not decrease. Instead CII amount may even increase if the cell initiates a mitochondrial 
biogenesis program to compensate for the functional defect. Thus, quantifying the ratios of the 
amounts of the other complexes to complex II may be useful. In addition, if a decrease in the 
amount of one complex is suspected, the individual subunits of that complex can be quantified 
by SDS-PAGE against housekeeping proteins and proteins indicating mitochondrial mass such as 
porin.  
 
 
Time Considerations 
For the in vivo and in organello translation assays, cells must be plated one day before the 
labeling. The labeling of the cells and the preparation of the samples takes one day for pulse 
experiment and one to two days for chase experiment. We recommend preparing the gel the 
day before the running of the samples. The running of the gel takes about 16 hours and can be 
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done overnight. Next day the gel is dried and exposed to the phosphor screen for one to five 
days depending on the freshness of the label and the amount of the protein in the gel. The gel 
can be stained with coomassie after imaging and the washing of the gel takes one day. Thus, 
the total time is about seven working days. 
In the nonradioactive mitochondrial translation assay, the cells must be plated one day 
before the actual experiment. The protein extraction, gel running and immunoblotting takes 
three days. Altogether, the whole experiment takes four days. 
In the BN-PAGE cells must be plated one day before the actual experiment. We recommend 
preparing the gel and the buffers the day before PAGE. The protein extraction takes half a day 
and the gel running and western blotting one whole day. The immunoblotting with five OXPHOS 
complex antibodies sequentially takes five days. Altogether, the entire experiment takes about 
8 working days. 
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FIGURE LEGENDS 
 
Figure 1.  
A) In vivo mitochondrial translation assay in monkey kidney cells (COS-7). Newly synthesized 
mitochondrial proteins were pulse (1 h) or chase (27 h) labeled with [
35
S] in control cells (Ctrl) 
or in cells treated with an arginine analog, canavanine (CAN). The 13 mtDNA-encoded proteins 
that are radioactively labeled are marked in the gel image. ND4 and ATP8 subunits appear as a 
single band. Coomassie staining is shown to allow comparison of protein loading. Pulse labeling 
shows that canavanine treatment induced aberrantly sized polypeptides in the proximity of 
COX2/COX3 subunits (marked with asterisks). Chase labeling reveals reduced stability of 
mtDNA-encoded proteins in canavanine treated cells. 
B) Immunoblot of BN-PAGE of OXPHOS complexes isolated from HEK293 cells. Complexes I to IV 
were detected using antibodies to the indicated complex subunits. 
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